ARS Pharmaceuticals, Inc (SPRY) — Free Cash Flow Generation Index
ARS Pharmaceuticals, Inc (SPRY) has a Free Cash Flow Generation Index of 0.99x as of December 2024. Free cash flow of $41.70 Million represents 1% of operating cash flow ($42.00 Million). See ARS Pharmaceuticals, Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
ARS Pharmaceuticals, Inc Free Cash Flow Generation Index (2020–2024)
Historical FCF Generation Index trend for ARS Pharmaceuticals, Inc across 2 annual periods. Explore SPRY operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for ARS Pharmaceuticals, Inc (2020–2024)
Year-by-year Free Cash Flow Generation Index for ARS Pharmaceuticals, Inc. For the full company profile including market capitalisation, see SPRY market cap.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.96x | $12.98 Million | $13.55 Million | $563.00K | ▲ +6.6% |
| 2020 | 0.90x | $8.15 Million | $9.07 Million | $917.00K | — |